Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Natural Sources and Anti-in?ammatory Activity of Astragalin
Astragalin suppresses the viability and migration of cancer cells without exhibiting cytotoxicity toward normal human colonic epithelial cells (NCM460).
Mar 28,2026 APIClinical Research and Toxicological assessment of Clindamycin phosphate
Clindamycin phosphate has significant antibacterial effects against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus species.
Mar 28,2026 APISynthesis and Condensation reaction of (R)-(-)-3-Chloro-1,2-propanediol
(R)-(-)-3-Chloro-1,2-propanediol has a wide range of applications in the pharmaceutical and chemical manufacturing fields.
Mar 28,2026 APIMetabolism and Pharmacodynamic Properties of Atenolol
Atenolol is primarily used for the treatment of hypertension, angina pectoris, and myocardial infarction, and may also be used for arrhythmias.
Mar 26,2026 APINucleophilic aromatic substitution and Methylation reaction of 2,4-Dichloropyrimidine
2,4-dichloropyrimidine's two reactive chlorine atoms, positioned at the 2 and 4 positions of the pyrimidine ring, exhibit differential reactivity.
Mar 24,2026 APIBiological research and Neurotoxicity of Poly(hexamethylenebicyanoguanide-hexamethylenediamine) hydrochloride
Poly(hexamethylenebicyanoguanide-hexamethylenediamine) hydrochloride exhibits biocidal activity against Gram-positive bacteria.
Mar 23,2026 APIPreparation Methods and Acylation reaction of Ethyl cyanoglyoxylate-2-oxime
Ethyl cyanoglyoxylate-2-oxime is commonly used as an intermediate in chemical synthesis, particularly in the production of other organic compounds.
Mar 23,2026 APIBisphenoxyethanolfluorene: Monomer & Toxicity
Bisphenoxyethanolfluorene is a fluorene-based diol monomer for high-performance resins and optical materials, with strong antiestrogenic activity.
Mar 22,2026 API4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene: Building Block for Cross-Coupling
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene is a diphenylmethane building block for cross-coupling reactions and used in downstream organic synthesis.
Mar 22,2026 APICefoxitin Sodium: Antibiotic Profile & Clinical Applications
Cefoxitin sodium is an intravenous cephamycin antibiotic, is stable to many beta-lactamases, and shows similar 30-day efficacy to carbapenems.
Mar 20,2026 API












